Neuraminidase inhibitors for influenza complications: authors' reply

QR Code

Neuraminidase inhibitors for influenza complications: authors' reply

Bibliographic Details
Main Authors:	Nguyen-Van-Tam, Jonathan S., Openshaw, Peter J.M., Nicholson, K.G.
Format:	Article
Published:	Elsevier 2014
Online Access:	https://eprints.nottingham.ac.uk/41888/

Similar Items

Antivirals for influenza: where now for clinical practice and pandemic preparedness?
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2014)

Neuraminidase inhibitors: who, when, where?
by: Nguyen-Van-Tam, Jonathan S., et al.
Published: (2015)

Clinicians' attitude towards a placebo-controlled randomised clinical trial investigating the effect of neuraminidase inhibitors in adults hospitalised with influenza
by: Bradbury, Naomi, et al.
Published: (2018)

Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies
by: Okoli, G.N., et al.
Published: (2014)

Statistical and methodological concerns about the beneficial effect of neuraminidase inhibitors on mortality
by: Leonardi-Bee, Jo, et al.
Published: (2014)

Author reply
by: Campbell, D., et al.
Published: (2013)

Virtual High Throughput Screening For Avian Influenza (H5nl) Neuraminidase Inhibitors
by: Ismail, Nurul Izza
Published: (2011)

Impact of neuraminidase inhibitor treatment on hospitalisation in patients with pandemic influenza: a multi-method modelling approach
by: Venkatesan, Sudhir
Published: (2019)

Reply to Jones et al
by: Venkatesan, Sudhir, et al.
Published: (2017)

Re: Authors' reply to Stockwell and colleagues
by: Daube, Mike
Published: (2012)

Expectant management in pregnancies with ruptured membranes – Authors' reply
by: Morris, Jonathan M., et al.
Published: (2016)

Modelling And Syntheses Of Vanillin Derivatives Targeting Influenza Virus Neuraminidase
by: Asaruddin, Mohd Razip
Published: (2016)

Impact of neuraminidase inhibitors on influenza A(H1N1)pdm09‐related pneumonia: an individual participant data meta‐analysis
by: Muthuri, Stella G., et al.
Published: (2016)

In silico study of carvone derivatives as potential neuraminidase inhibitors
by: Jusoh, Noorakmar, et al.
Published: (2018)

Cochrane column
by: Nguyen-Van-Tam, J.S., et al.
Published: (2014)

Reply: Letter to the editor, Cochrane rearranged
by: Beyer, W.E.P., et al.
Published: (2015)

Impact of outpatient neuraminidase inhibitor treatment in patients infected with influenza A(H1N1)pdm09 at high risk of hospitalization: an Individual Participant Data (IPD) meta-analysis
by: Venkatesan, Sudhir, et al.
Published: (2017)

Effect of ethnicity on care pathway and outcomes in patients hospitalized with influenza A(H1N1)pdm09 in the UK
by: Nyland, G.A., et al.
Published: (2014)

Statins for people at low risk of cardiovascular disease: Authors' reply
by: Zomer, E., et al.
Published: (2012)

Influenza in long-term care facilities
by: Lansbury, Louise E., et al.
Published: (2017)

In reply
by: Hillman, D., et al.
Published: (2010)

Synthesis and molecular docking of carvone derivatives as a potential neuraminidase inhibitors
by: Jusoh, Noorakmar, et al.
Published: (2016)

Identification Of Potential Neuraminidase Inhibitors Using Ensemble-Based Virtual Screening
by: Lim, Kok Keong
Published: (2013)

Principal author of PRIDE study responds to news story in the BMJ claiming that the study was based on "flawed" analysis
by: Nguyen-Van-Tam, Jonathan S.
Published: (2014)

The environmental deposition of influenza virus from patients infected with influenza A(H1N1)pdm09: implications for infection prevention and control
by: Killingley, Ben, et al.
Published: (2015)

Potential Neuraminidase Inhibitors Via Virtual Screening, Kinetic Studies, And Adme Predictions
by: Nuwarda, Rina Fajri
Published: (2015)

Computer-Aided Drug Design Of Potential Neuraminidase Inhibitors From Plant Extracts
by: Muchtaridi, Muchtaridi
Published: (2013)

Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
by: Muthuri, Stella G., et al.
Published: (2014)

Corticosteroids as adjunctive therapy in the treatment of influenza
by: Rodrigo, Chamira, et al.
Published: (2016)

Comparison of vaccine efficacy must be based on good clinical data–Authors’ reply
by: Abdul Taib, Nur Asheila, et al.
Published: (2022)

Practical prevention of nosocomial influenza transmission, 'a hierarchical control' issue
by: O'Reilly, Frank, et al.
Published: (2015)

In reply
by: Ing, C., et al.
Published: (2015)

In reply
by: Said, J., et al.
Published: (2010)

Peptide inhibitors against influenza virus
by: Mohamed Ibrhaim, Mohamed Rajik, et al.
Published: (2011)

Heterologous Expression Of Avian Influenza A (H5n1) Neuraminidase In Kluyveromyces Lactis And Escherichia Coli
by: Taufik, Noor Zafiah
Published: (2016)

The child support grant and adolescent risk of HIV infection in South Africa – Authors' reply
by: Cluver, L., et al.
Published: (2014)

Neratinib after trastuzumab in patients with HER2-positive breast cancer - Author's reply
by: Chan, Arlene, et al.
Published: (2016)

Rational Design And Synthesis Of Inhibitors For H1n1 Neuraminidase And Dengue Protease Enzymes
by: Hariono, Maywan
Published: (2015)

Authors’ reply: Comment on: Teaching metacognition in clinical decision-making using a novel mnemonic checklist: an exploratory study
by: Chew, KS, et al.
Published: (2017)

Influenza vaccines really work? Keeping apart the true from the false
by: Nguyen-Van-Tam, Jonathan, et al.
Published: (2015)